Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Rising Pharma Holding, Inc. recalls Duloxetine DR Capsules USP 60 mg

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
Products
  • Duloxetine DR Capsules USP 60 mg
Where it was sold

Nationwide.

Nationwide

Units affected
233,003 bottles
About this recall
Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c) 1000 count (NDC 57237-019-99) bottles, Distributed by: Rising Pharmaceuticals, Inc., East Brunswick, NJ